Dopamine, noradrenaline and serotonin spinal fluid metabolites in temporal lobe epileptic patients with schizophrenic symptomatology.
Cerebrospinal fluid metabolites of dopamine, norepinephrine and serotonin were studied in two groups of left temporal lobe epileptic patients, the only difference between the two groups being that one group had paranoid schizophrenic symptomatology. Homovanillic acid accumulation was decreased in this group. This finding may be a biochemical indicator of a genetic predisposition to schizophrenic symptomatology in certain epileptic patients.
D000293:Adolescent; D000328:Adult; D002648:Child; D004298:Dopamine / Q000134:cerebrospinal fluid*; D004833:Epilepsy, Temporal Lobe / Q000134:cerebrospinal fluid* / Q000150:complications; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D009638:Norepinephrine / Q000134:cerebrospinal fluid*; D010634:Phenobarbital / Q000134:cerebrospinal fluid; D012559:Schizophrenia / Q000134:cerebrospinal fluid* / Q000150:complications; D012701:Serotonin / Q000134:cerebrospinal fluid*
D012701:Serotonin; D008734:Methoxyhydroxyphenylglycol; D006897:Hydroxyindoleacetic Acid; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid; D010634:Phenobarbital